We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Pacemaker Responds to Direct Signals from Heart

By HospiMedica staff writers
Posted on 24 Jan 2003
A new type of pacemaker utilizes closed-loop simulation (CLS) technology for rate-adaptive pacing, which translates cardiac signals sent directly from the heart to determine appropriate heart rate.

Older pacemakers respond only when patients are in motion or when their breathing rate changes. More...
The new pacemaker responds quickly not only to demands caused by physical exertion but also to those triggered by mental demands and emotional stress. Called Protos, the pacemaker also offers flexible programming and arrhythmia detection. Because the pacemaker does not require special leads, most existing pacemaker patients are candidates for Protos whenever replacement of current devices becomes necessary. Protos was developed by Biotronik (Berlin, Germany; www.biotronik.com) and has been cleared by the US Food and Drug Administration (FDA).

"Protos is the only pacemaker currently available that is capable of interpreting what the autonomic nervous system is really demanding from the heart, and responding in a manner that mimics the natural rhythm changes of a healthy heart,” said William Bailey, M.D., a cardiac electrophysiologist at the Heart & Vascular Center in Lake Charles, LA (USA) who served as the principal investigator in the FDA trials. Protos also adjusts automatically to changes in a patient's heart condition or medications.




Related Links:
Biotronik

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.